vs

Side-by-side financial comparison of Inogen Inc (INGN) and PennyMac Mortgage Investment Trust (PMT). Click either name above to swap in a different company.

PennyMac Mortgage Investment Trust is the larger business by last-quarter revenue ($93.6M vs $68.6M, roughly 1.4× Inogen Inc). On growth, Inogen Inc posted the faster year-over-year revenue change (3.4% vs -13.3%). Over the past eight quarters, PennyMac Mortgage Investment Trust's revenue compounded faster (12.3% CAGR vs 4.2%).

Inogen Inc is a medical technology firm specializing in the development, production and distribution of portable oxygen concentrators and associated respiratory care products. It caters primarily to patients with chronic respiratory conditions needing long-term oxygen therapy across North America, Europe and other global markets, focusing on home care and ambulatory patient segments to enhance users' quality of life.

PennyMac Mortgage Investment Trust is a U.S.-headquartered real estate investment trust specializing in residential mortgage assets. It invests in performing and non-performing mortgage loans, mortgage-backed securities, and credit risk transfer instruments, operating across investment management and mortgage servicing segments in the U.S. housing market.

INGN vs PMT — Head-to-Head

Bigger by revenue
PMT
PMT
1.4× larger
PMT
$93.6M
$68.6M
INGN
Growing faster (revenue YoY)
INGN
INGN
+16.7% gap
INGN
3.4%
-13.3%
PMT
Faster 2-yr revenue CAGR
PMT
PMT
Annualised
PMT
12.3%
4.2%
INGN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
INGN
INGN
PMT
PMT
Revenue
$68.6M
$93.6M
Net Profit
$52.4M
Gross Margin
51.4%
Operating Margin
-13.6%
38.6%
Net Margin
56.0%
Revenue YoY
3.4%
-13.3%
Net Profit YoY
12.5%
EPS (diluted)
$-0.26
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
INGN
INGN
PMT
PMT
Q4 25
$68.6M
$93.6M
Q3 25
$79.1M
$99.2M
Q2 25
$79.2M
$70.2M
Q1 25
$68.5M
$44.5M
Q4 24
$66.3M
$107.9M
Q3 24
$74.9M
$80.9M
Q2 24
$74.4M
$71.2M
Q1 24
$63.1M
$74.2M
Net Profit
INGN
INGN
PMT
PMT
Q4 25
$52.4M
Q3 25
$-5.3M
$58.3M
Q2 25
$-4.2M
$7.5M
Q1 25
$-6.2M
$9.7M
Q4 24
$46.5M
Q3 24
$-6.0M
$41.4M
Q2 24
$-5.6M
$25.4M
Q1 24
$-14.6M
$47.6M
Gross Margin
INGN
INGN
PMT
PMT
Q4 25
51.4%
Q3 25
52.2%
Q2 25
52.2%
Q1 25
53.1%
Q4 24
54.7%
Q3 24
55.2%
Q2 24
57.4%
Q1 24
54.5%
Operating Margin
INGN
INGN
PMT
PMT
Q4 25
-13.6%
38.6%
Q3 25
-9.0%
47.4%
Q2 25
-7.7%
24.2%
Q1 25
-11.2%
-14.2%
Q4 24
-17.2%
51.1%
Q3 24
-10.4%
32.8%
Q2 24
-9.5%
40.2%
Q1 24
-25.8%
43.6%
Net Margin
INGN
INGN
PMT
PMT
Q4 25
56.0%
Q3 25
-6.7%
58.7%
Q2 25
-5.2%
10.7%
Q1 25
-9.0%
21.8%
Q4 24
43.1%
Q3 24
-8.0%
51.2%
Q2 24
-7.5%
35.7%
Q1 24
-23.1%
64.2%
EPS (diluted)
INGN
INGN
PMT
PMT
Q4 25
$-0.26
$0.49
Q3 25
$-0.20
$0.55
Q2 25
$-0.15
$-0.04
Q1 25
$-0.25
$-0.01
Q4 24
$-0.41
$0.45
Q3 24
$-0.25
$0.36
Q2 24
$-0.24
$0.17
Q1 24
$-0.62
$0.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
INGN
INGN
PMT
PMT
Cash + ST InvestmentsLiquidity on hand
$103.7M
$190.5M
Total DebtLower is stronger
$1.1B
Stockholders' EquityBook value
$192.2M
$1.9B
Total Assets
$298.6M
$21.3B
Debt / EquityLower = less leverage
0.58×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
INGN
INGN
PMT
PMT
Q4 25
$103.7M
$190.5M
Q3 25
$106.5M
$181.0M
Q2 25
$103.7M
$108.6M
Q1 25
$118.9M
$204.2M
Q4 24
$113.8M
$103.2M
Q3 24
$105.7M
$102.8M
Q2 24
$97.9M
$336.3M
Q1 24
$107.4M
$343.3M
Total Debt
INGN
INGN
PMT
PMT
Q4 25
$1.1B
Q3 25
$299.0M
Q2 25
$1.2B
Q1 25
$968.4M
Q4 24
$1.0B
Q3 24
$5.2B
Q2 24
$5.4B
Q1 24
$5.1B
Stockholders' Equity
INGN
INGN
PMT
PMT
Q4 25
$192.2M
$1.9B
Q3 25
$197.2M
$1.9B
Q2 25
$199.5M
$1.9B
Q1 25
$198.0M
$1.9B
Q4 24
$173.9M
$1.9B
Q3 24
$185.4M
$1.9B
Q2 24
$187.6M
$1.9B
Q1 24
$191.9M
$2.0B
Total Assets
INGN
INGN
PMT
PMT
Q4 25
$298.6M
$21.3B
Q3 25
$307.0M
$18.5B
Q2 25
$312.0M
$16.8B
Q1 25
$308.4M
$14.9B
Q4 24
$296.2M
$14.4B
Q3 24
$306.2M
$13.1B
Q2 24
$308.9M
$12.1B
Q1 24
$315.6M
$12.3B
Debt / Equity
INGN
INGN
PMT
PMT
Q4 25
0.58×
Q3 25
0.16×
Q2 25
0.65×
Q1 25
0.51×
Q4 24
0.52×
Q3 24
2.70×
Q2 24
2.76×
Q1 24
2.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
INGN
INGN
PMT
PMT
Operating Cash FlowLast quarter
$-943.0K
$-7.2B
Free Cash FlowOCF − Capex
$-1.9M
FCF MarginFCF / Revenue
-2.8%
Capex IntensityCapex / Revenue
1.4%
Cash ConversionOCF / Net Profit
-137.76×
TTM Free Cash FlowTrailing 4 quarters
$-13.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
INGN
INGN
PMT
PMT
Q4 25
$-943.0K
$-7.2B
Q3 25
$2.2M
$-1.3B
Q2 25
$4.3M
$-2.0B
Q1 25
$-16.8M
$-594.3M
Q4 24
$-3.0M
$-2.7B
Q3 24
$7.0M
$-983.8M
Q2 24
$6.7M
$243.8M
Q1 24
$-4.7M
$-342.4M
Free Cash Flow
INGN
INGN
PMT
PMT
Q4 25
$-1.9M
Q3 25
$1.6M
Q2 25
$3.7M
Q1 25
$-17.1M
Q4 24
$-3.3M
Q3 24
$5.3M
Q2 24
$6.6M
Q1 24
$-6.1M
FCF Margin
INGN
INGN
PMT
PMT
Q4 25
-2.8%
Q3 25
2.0%
Q2 25
4.6%
Q1 25
-24.9%
Q4 24
-5.0%
Q3 24
7.1%
Q2 24
8.9%
Q1 24
-9.6%
Capex Intensity
INGN
INGN
PMT
PMT
Q4 25
1.4%
Q3 25
0.7%
Q2 25
0.9%
Q1 25
0.4%
Q4 24
0.5%
Q3 24
2.2%
Q2 24
0.1%
Q1 24
2.1%
Cash Conversion
INGN
INGN
PMT
PMT
Q4 25
-137.76×
Q3 25
-22.26×
Q2 25
-267.53×
Q1 25
-61.39×
Q4 24
-58.08×
Q3 24
-23.76×
Q2 24
9.59×
Q1 24
-7.19×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

INGN
INGN

Other$36.1M53%
Non Us$32.5M47%

PMT
PMT

Other$55.0M59%
Interest Rate Sensitive Strategies$31.4M34%
Correspondent Production$7.2M8%

Related Comparisons